Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 7.452
Filter
1.
Ecotoxicol Environ Saf ; 281: 116646, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38954906

ABSTRACT

Agricultural production relies heavily on the use of pesticides, which may accumulate in soil and water, posing a significant threat to the global ecological environment and biological health. Butachlor is a commonly used herbicide and environmental pollutant, which has been linked to liver and kidney damage, as well as neurological abnormalities. However, the potential impact of butachlor exposure on the gut microbiota remains understudied. Thus, our aim was to investigate the potential negative effects of butachlor exposure on host health and gut microbiota. Our results demonstrated that butachlor exposure significantly reduced the host antioxidant capacity, as evidenced by decreased levels of T-AOC, SOD, and GSH-Px, and increased levels of MDA. Serum biochemical analysis also revealed a significant increase in AST and ALT levels during butachlor exposure. Microbial analysis showed that butachlor exposure significantly reduced the abundance and diversity of gut microbiota. Furthermore, butachlor exposure also significantly altered the gut microbial composition. In conclusion, our findings indicate that butachlor exposure can have detrimental health effects, including dysregulation of antioxidant enzymes, abnormalities in transaminases, and hepatointestinal damage. Furthermore, it disrupts the gut microbial homeostasis by altering microbial composition and reducing diversity and abundance. In the context of the increasingly serious use of pesticides, this study will help provide impetus for standardizing the application of pesticides and reducing environmental pollution.


Subject(s)
Acetanilides , Gastrointestinal Microbiome , Homeostasis , Gastrointestinal Microbiome/drug effects , Homeostasis/drug effects , Animals , Acetanilides/toxicity , Herbicides/toxicity , Pesticides/toxicity , Male , Antioxidants/metabolism , Environmental Pollutants/toxicity
2.
Sci Rep ; 14(1): 16082, 2024 Jul 12.
Article in English | MEDLINE | ID: mdl-38992091

ABSTRACT

Regulation of physiological homeostasis, including energy balance, is thought to be modified by low levels of adult neurogenesis in the hypothalamus. Hormones such as oestradiol can influence both embryonic and adult hypothalamic neurogenic programs, demonstrating a sensitivity of hypothalamic neural progenitor cells to endogenous hormones. Previously we showed that gestational exposure to environmental levels of the xenoestrogen bisphenol A (BPA) changed neural progenitor cell behaviors in the embryo; however, we did not examine if these changes were permanent to affect adult neurogenesis. Here we investigated whether adult neuro- and/or gliogenesis were altered in mice prenatally exposed to BPA and placed on a high-fat diet challenge. Gestationally exposed adult female mice on a standard diet gained less weight than non-BPA controls, whereas gestationally exposed BPA females on a high-fat diet gained more weight than controls. Males exposed to gestational BPA showed no differences in weight gain relative to control males. Concomitantly, adult neurogenesis was increased in the VMH, DMH, and PVN of adult female mice exposed to BPA on standard diet, suggesting that disrupted adult neurogenesis might perturb normal energy balance regulation in females. These results add to growing evidence that low-dose BPA exposure in utero causes changes to adult hypothalamic function.


Subject(s)
Benzhydryl Compounds , Energy Metabolism , Homeostasis , Hypothalamus , Neurogenesis , Phenols , Prenatal Exposure Delayed Effects , Animals , Benzhydryl Compounds/toxicity , Female , Phenols/toxicity , Neurogenesis/drug effects , Pregnancy , Mice , Hypothalamus/drug effects , Hypothalamus/metabolism , Prenatal Exposure Delayed Effects/chemically induced , Homeostasis/drug effects , Energy Metabolism/drug effects , Male , Diet, High-Fat/adverse effects
3.
Sci Rep ; 14(1): 16997, 2024 Jul 23.
Article in English | MEDLINE | ID: mdl-39043847

ABSTRACT

Vitamin D3 is clinically used for the treatment of vitamin D3 deficiency or osteoporosis, partially because of its role in regulating phosphate (Pi) and calcium (Ca2+) homeostasis. The renal sodium-phosphate cotransporter 2a (Npt2a) plays an important role in Pi homeostasis; however, the role of vitamin D3 in hypophosphatemia has never been investigated. We administered vehicle or vitamin D3 to wild-type (WT) mice or hypophosphatemic Npt2a-/- mice. In contrast to WT mice, vitamin D3 treatment increased plasma Pi levels in Npt2a-/- mice, despite similar levels of reduced parathyroid hormone and increased fibroblast growth factor 23. Plasma Ca2+ was increased ~ twofold in both genotypes. Whereas WT mice were able to increase urinary Pi and Ca2+/creatinine ratios, in Npt2a-/- mice, Pi/creatinine was unchanged and Ca2+/creatinine drastically decreased, coinciding with the highest kidney Ca2+ content, highest plasma creatinine, and greatest amount of nephrocalcinosis. In Npt2a-/- mice, vitamin D3 treatment completely diminished Npt2c abundance, so that mice resembled Npt2a/c double knockout mice. Abundance of intestinal Npt2b and claudin-3 (tight junctions protein) were reduced in Npt2a-/- only, the latter might facilitate the increase in plasma Pi in Npt2a-/- mice. Npt2a might function as regulator between renal Ca2+ excretion and reabsorption in response to vitamin D3.


Subject(s)
Calcium , Cholecalciferol , Homeostasis , Mice, Knockout , Phosphates , Sodium-Phosphate Cotransporter Proteins, Type IIa , Animals , Phosphates/metabolism , Calcium/metabolism , Homeostasis/drug effects , Mice , Cholecalciferol/pharmacology , Cholecalciferol/metabolism , Sodium-Phosphate Cotransporter Proteins, Type IIa/metabolism , Sodium-Phosphate Cotransporter Proteins, Type IIa/genetics , Kidney/metabolism , Kidney/drug effects , Fibroblast Growth Factor-23 , Parathyroid Hormone/metabolism , Male , Hypophosphatemia/metabolism , Hypophosphatemia/genetics , Sodium-Phosphate Cotransporter Proteins, Type IIb
4.
Aging (Albany NY) ; 16(13): 11062-11071, 2024 Jul 05.
Article in English | MEDLINE | ID: mdl-38975935

ABSTRACT

OBJECTIVE: To investigate the effect of sevoflurane on neuropathic pain induced by chronic constriction injury (CCI) of sciatic nerve in mice, and to elucidate its mechanism by animal experiments. METHODS AND RESULTS: Thirty-two C57BL/6 mice were randomly divided into four groups: Sham group, Model group, Control group and Sevoflurane group. First, a mouse model of neuropathic pain was established. Then, the mice in each group were killed on Day 14 after operation to harvest the enlarged lumbosacral spinal cord. In contrast with the Model group, the Sevoflurane group displayed a significantly increased paw withdrawal mechanical threshold (PWMT) and significantly prolonged paw withdrawal thermal latency (PWTL) from Day 5 after operation. The morphological changes of lumbosacral spinal cord were observed by hematoxylin-eosin (HE) staining and transmission electron microscopy. Pathological results showed that sevoflurane reduced nuclear pyknosis in lumbosacral spinal cord tissue, with a large number of mitochondrial crista disappearance and mitochondrial swelling. The results of Western blotting showed that sevoflurane significantly decreased the protein expressions of phosphorylated phospholipase Cγ (p-PLCγ), phosphorylated calcium/calmodulin-dependent protein kinase II (p-CaMKII) and phosphorylated inositol 1,4,5-triphosphate receptor (p-IP3R), and reduced the protein expressions of endoplasmic reticulum (ER) stress proteins glucose-regulated protein 78 (GRP78) and GRP94, oxidative stress-related proteins P22 and P47 and inflammatory factors nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3), interleukin-1 ß (IL-1ß), and tumor necrosis factor-α (TNF-α). CONCLUSIONS: Sevoflurane inhibits neuropathic pain by maintaining ER stress and oxidative stress homeostasis through inhibiting the activation of the PLCγ/CaMKII/IP3R signaling pathway.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinase Type 2 , Endoplasmic Reticulum Chaperone BiP , Endoplasmic Reticulum Stress , Inositol 1,4,5-Trisphosphate Receptors , Mice, Inbred C57BL , Neuralgia , Oxidative Stress , Phospholipase C gamma , Sevoflurane , Signal Transduction , Animals , Sevoflurane/pharmacology , Endoplasmic Reticulum Stress/drug effects , Neuralgia/metabolism , Neuralgia/drug therapy , Signal Transduction/drug effects , Oxidative Stress/drug effects , Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism , Mice , Phospholipase C gamma/metabolism , Inositol 1,4,5-Trisphosphate Receptors/metabolism , Male , Spinal Cord/metabolism , Spinal Cord/drug effects , Spinal Cord/pathology , Homeostasis/drug effects , Disease Models, Animal , Sciatic Nerve/drug effects , Sciatic Nerve/metabolism , Sciatic Nerve/injuries
5.
Sci Rep ; 14(1): 16823, 2024 Jul 22.
Article in English | MEDLINE | ID: mdl-39039220

ABSTRACT

Exploring host plant resistance and elevating plant defense mechanisms through the application of exogenous elicitors stands as a promising strategy for integrated pest management. The fall armyworm, a pernicious menace to grain crops in tropical and subtropical regions, stands as a formidable threat due to its capacity for devastation and a wide-ranging spectrum of host plants. There is no literature regarding artificially induced resistance in maize against fall armyworm (Spodoptera frugiperda) by exogenous application of phytohormones. The present investigation was performed to evaluate the role of jasmonic acid (JA) and salicylic acid (SA) on two maize hybrids namely FH-1046 and YH-1898 against fall armyworm. Results showed that plant height, biomass and lengths, fresh and dry weight of root shoot which decreased with armyworm infestation improved with phytohormonal application. JA treatment resulted in a higher increase in all attributes as compared to SA treatment. Improvement in relative water contents, photosynthetic pigments and pronounced levels of phenol and proline accumulation were observed in infested plants after JA treatment. Infested plants recovered from oxidative stress as JA application activated and increased the antioxidant enzyme activity of superoxide dismutase, peroxidase and polyphenol oxidase activity in both FH-1046 and YH-1898 . The oxidative stress reduction in infested plants after JA treatment was also evident from a fair decrease in MDA and H2O2 in both varieties. The SA and JA mediated genes expression was studied and it was found that in FH1046 maize cultivar, JA dependent genes, particularly marker genes PR1 and Lox5 were highly expressed along with TPS10 and BBT12. Whereas SPI, WRKY28, ICS and PAL were shown to be activated upon SA application. Evidently, both JA and SA elicited a robust defensive response within the maize plants against the voracious S. frugiperda, which in consequence exerted a discernible influence over the pest's developmental trajectory and physiological dynamics. A decrease in detoxification enzyme activity of the insects was observed after feeding on treated plants. Moreover, it was recorded that the survival and weight gain of FAW feeding on phytohormone treated maize plants also decelerated. In conclusion, FH-1046 was found to be more tolerant than YH-1898 against fall armyworm infestation and 1 mM JA was more effective than 1 mM SA for alleviation of fall armyworm stress. Therefore, it was inferred that phytohormones regulated redox homeostasis to circumvent oxidative damage and mediate essential metabolic events in maize under stress. To our current understanding, this study is the very first presentation of induced resistance in maize against S. frugiperda with the phytohormonal application (JA and SA).


Subject(s)
Cyclopentanes , Oxylipins , Salicylic Acid , Spodoptera , Zea mays , Zea mays/parasitology , Zea mays/metabolism , Zea mays/drug effects , Zea mays/genetics , Spodoptera/drug effects , Animals , Salicylic Acid/metabolism , Salicylic Acid/pharmacology , Cyclopentanes/pharmacology , Cyclopentanes/metabolism , Oxylipins/metabolism , Oxylipins/pharmacology , Oxidation-Reduction/drug effects , Homeostasis/drug effects , Plant Growth Regulators/pharmacology , Plant Growth Regulators/metabolism , Plant Diseases/parasitology , Oxidative Stress/drug effects
6.
Curr Gene Ther ; 24(5): 410-421, 2024.
Article in English | MEDLINE | ID: mdl-39005063

ABSTRACT

BACKGROUND: Injury systemically disrupts the homeostatic balance and can cause organ failure. LF mediates both iron-dependent and iron-independent mechanisms, and the role of LF in regulating iron homeostasis is vital in terms of metabolism. OBJECTIVES: In this study, we evaluated the organ-level effect and gene expression change of bLf in the cutaneous repair process. MATERIALS AND METHODS: An excisional full-thickness skin defect (FTSD) wound model was created in male Sprague Dawley rats (180-250 g) (n = 48) fed a high-fat diet (HFD) and the PHGPx, SLC7A11 and SLC40A1 genes and iron metabolism were evaluated. The animals were randomly divided into 6 groups: 1- Control, 2- bLf (200 mg/kg/day, oral), 3- FTSD (12 mm in diameter, dorsal), 4- HFD + bLf, 5- HFD + FTSD, 6- HFD + FTSD + bLf. Histologically, iron accumulation was demonstrated by Prussian blue staining in the liver, kidney, and intestinal tissues. Gene expression analysis was performed with qPCR. RESULTS: Histologically, iron accumulation was demonstrated by Prussian blue staining in the liver, kidney, and intestinal tissues. Prussian blue reactions were detected in the kidney. PHPGx and SLC7A11 genes in kidney and liver tissue were statistically significant (P < 0.05) except for the SLC40A1 gene (P > 0.05). Expression changes of the three genes were not statistically significant in analyses of rat intestinal tissue (P = 0.057). CONCLUSION: In the organ-level ferroptotic damage mechanism triggered by wound formation. BLf controls the expression of three genes and manages iron deposition in these three tissues. In addition, it suppressed the increase in iron that would drive the cell to ferroptosis and anemia caused by inflammation, thereby eliminating iron deposition in the tissues.


Subject(s)
Homeostasis , Iron , Lactoferrin , Rats, Sprague-Dawley , Wound Healing , Animals , Iron/metabolism , Rats , Male , Homeostasis/drug effects , Lactoferrin/pharmacology , Lactoferrin/genetics , Wound Healing/drug effects , Wound Healing/genetics , Cattle , Multiple Organ Failure/genetics , Multiple Organ Failure/metabolism , Multiple Organ Failure/drug therapy , Cation Transport Proteins/genetics , Cation Transport Proteins/metabolism , Gene Expression Regulation/drug effects , Liver/metabolism , Liver/drug effects
7.
Sci Rep ; 14(1): 15683, 2024 Jul 08.
Article in English | MEDLINE | ID: mdl-38977794

ABSTRACT

We explored physiological effects of the sodium-glucose co-transporter-2 inhibitor empagliflozin on intact experimentally hypertrophic murine hearts following transverse aortic constriction (TAC). Postoperative drug (2-6 weeks) challenge resulted in reduced late Na+ currents, and increased phosphorylated (p-)CaMK-II and Nav1.5 but not total (t)-CaMK-II, and Na+/Ca2+ exchanger expression, confirming previous cardiomyocyte-level reports. It rescued TAC-induced reductions in echocardiographic ejection fraction and fractional shortening, and diastolic anterior and posterior wall thickening. Dual voltage- and Ca2+-optical mapping of Langendorff-perfused hearts demonstrated that empagliflozin rescued TAC-induced increases in action potential durations at 80% recovery (APD80), Ca2+ transient peak signals and durations at 80% recovery (CaTD80), times to peak Ca2+ (TTP100) and Ca2+ decay constants (Decay30-90) during regular 10-Hz stimulation, and Ca2+ transient alternans with shortening cycle length. Isoproterenol shortened APD80 in sham-operated and TAC-only hearts, shortening CaTD80 and Decay30-90 but sparing TTP100 and Ca2+ transient alternans in all groups. All groups showed similar APD80, and TAC-only hearts showed greater CaTD80, heterogeneities following isoproterenol challenge. Empagliflozin abolished or reduced ventricular tachycardia and premature ventricular contractions and associated re-entrant conduction patterns, in isoproterenol-challenged TAC-operated hearts following successive burst pacing episodes. Empagliflozin thus rescues TAC-induced ventricular hypertrophy and systolic functional, Ca2+ homeostatic, and pro-arrhythmogenic changes in intact hearts.


Subject(s)
Benzhydryl Compounds , Calcium , Glucosides , Homeostasis , Animals , Benzhydryl Compounds/pharmacology , Glucosides/pharmacology , Mice , Calcium/metabolism , Homeostasis/drug effects , Male , Action Potentials/drug effects , Arrhythmias, Cardiac/metabolism , Arrhythmias, Cardiac/drug therapy , Sodium-Glucose Transporter 2 Inhibitors/pharmacology , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/metabolism , NAV1.5 Voltage-Gated Sodium Channel/metabolism , Sodium-Calcium Exchanger/metabolism , Aorta/drug effects , Aorta/metabolism , Aorta/surgery , Mice, Inbred C57BL , Isoproterenol/pharmacology , Disease Models, Animal
8.
Cells ; 13(14)2024 Jul 11.
Article in English | MEDLINE | ID: mdl-39056761

ABSTRACT

Necrotizing enterocolitis (NEC) is a complex, multifactorial gastrointestinal disorder predominantly affecting preterm infants. The pathogenesis of this condition involves a complex interplay between intestinal barrier dysfunction, microbial dysbiosis, and an altered immune response. This study investigates the potential role of endogenous hyaluronan (HA) in both the early phases of intestinal development and in the context of NEC-like intestinal injury. We treated neonatal CD-1 mouse pups with PEP1, a peptide inhibiting HA receptor interactions, from postnatal days 8 to 12. We evaluated postnatal intestinal developmental indicators, such as villi length, crypt depth, epithelial cell proliferation, crypt fission, and differentiation of goblet and Paneth cells, in PEP1-treated animals compared with those treated with scrambled peptide. PEP1 treatment significantly impaired intestinal development, as evidenced by reductions in villi length, crypt depth, and epithelial cell proliferation, along with a decrease in crypt fission activity. These deficits in PEP1-treated animals correlated with increased susceptibility to NEC-like injuries, including higher mortality rates, and worsened histological intestinal injury. These findings highlight the role of endogenous HA in supporting intestinal development and protecting against NEC.


Subject(s)
Enterocolitis, Necrotizing , Homeostasis , Hyaluronic Acid , Intestines , Animals , Hyaluronic Acid/pharmacology , Hyaluronic Acid/metabolism , Enterocolitis, Necrotizing/pathology , Enterocolitis, Necrotizing/metabolism , Enterocolitis, Necrotizing/drug therapy , Mice , Homeostasis/drug effects , Intestines/pathology , Intestines/drug effects , Cell Proliferation/drug effects , Animals, Newborn , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Intestinal Mucosa/drug effects , Disease Models, Animal
9.
Sci Rep ; 14(1): 15175, 2024 07 02.
Article in English | MEDLINE | ID: mdl-38956251

ABSTRACT

In the current study, we aimed to investigate whether disulfiram (DSF) exerts a neuroprotective role in cerebral ischemiareperfusion (CI-RI) injury by modulating ferredoxin 1 (FDX1) to regulate copper ion (Cu) levels and inhibiting inflammatory responses. To simulate CI-RI, a transient middle cerebral artery occlusion (tMCAO) model in C57/BL6 mice was employed. Mice were administered with or without DSF before and after tMCAO. Changes in infarct volume after tMCAO were observed using TTC staining. Nissl staining and hematoxylin-eosin (he) staining were used to observe the morphological changes of nerve cells at the microscopic level. The inhibitory effect of DSF on initial inflammation was verified by TUNEL assay, apoptosis-related protein detection and iron concentration detection. FDX1 is the main regulatory protein of copper death, and the occurrence of copper death will lead to the increase of HSP70 stress and inflammatory response. Cuproptosis-related proteins and downstream inflammatory factors were detected by western blotting, immunofluorescence staining, and immunohistochemistry. The content of copper ions was detected using a specific kit, while electron microscopy was employed to examine mitochondrial changes. We found that DSF reduced the cerebral infarction volume, regulated the expression of cuproptosis-related proteins, and modulated copper content through down regulation of FDX1 expression. Moreover, DSF inhibited the HSP70/TLR-4/NLRP3 signaling pathway. Collectively, DSF could regulate Cu homeostasis by inhibiting FDX1, acting on the HSP70/TLR4/NLRP3 pathway to alleviate CI/RI. Accordingly, DSF could mitigate inflammatory responses and safeguard mitochondrial integrity, yielding novel therapeutic targets and mechanisms for the clinical management of ischemia-reperfusion injury.


Subject(s)
Copper , Disulfiram , Homeostasis , Inflammation , Mice, Inbred C57BL , Reperfusion Injury , Animals , Reperfusion Injury/metabolism , Reperfusion Injury/drug therapy , Reperfusion Injury/pathology , Disulfiram/pharmacology , Mice , Copper/metabolism , Homeostasis/drug effects , Male , Inflammation/metabolism , Inflammation/drug therapy , Inflammation/pathology , Down-Regulation/drug effects , Infarction, Middle Cerebral Artery/metabolism , Infarction, Middle Cerebral Artery/drug therapy , Disease Models, Animal , Iron-Sulfur Proteins/metabolism , Brain Ischemia/metabolism , Brain Ischemia/drug therapy , Brain Ischemia/pathology , Apoptosis/drug effects , Mitochondria/metabolism , Mitochondria/drug effects , Neuroprotective Agents/pharmacology , Toll-Like Receptor 4/metabolism
10.
J Am Heart Assoc ; 13(13): e035990, 2024 Jul 02.
Article in English | MEDLINE | ID: mdl-38934871

ABSTRACT

BACKGROUND: Experimental preeclampsia (ePE) has been shown to have worsened outcome from stroke. We investigated the effect of low-dose aspirin, known to prevent preeclampsia, on stroke hemodynamics and outcome, and the association between the vasoconstrictor and vasodilator cyclooxygenase products thromboxane A2 and prostacyclin. METHODS AND RESULTS: Middle cerebral artery occlusion was performed for 3 hours with 1 hour of reperfusion in normal pregnant rats on day 20 of gestation and compared with ePE treated with vehicle or low-dose aspirin (1.5 mg/kg per day). Multisite laser Doppler was used to measure changes in cerebral blood flow to the core middle cerebral artery and collateral vascular territories. After 30 minutes occlusion, phenylephrine was infused to increase blood pressure and assess cerebral blood flow autoregulation. Infarct and edema were measured using 2,3,5-triphenyltetrazolium chloride staining. Plasma levels of thromboxane A2, prostacyclin, and inflammatory markers in plasma and cyclooxygenase levels in cerebral arteries were measured. ePE had increased infarction compared with normal pregnant rats (P<0.05) that was reduced by aspirin (P<0.001). ePE also had intact cerebral blood flow autoregulation and reduced collateral perfusion during induced hypertension that was also prevented by aspirin. Aspirin increased prostacyclin in ePE (P<0.05) without reducing thromboxane B2, metabolite of thromboxane A2, or 8-isoprostane-prostaglandin-2α, a marker of lipid peroxidation. There were no differences in cyclooxygenase levels in cerebral arteries between groups. CONCLUSIONS: Low-dose aspirin in ePE reduced infarction that was associated with increased vasodilator prostacyclin and improved collateral perfusion during induced hypertension. The beneficial effect of aspirin on the brain and cerebral circulation is likely multifactorial and worth further study.


Subject(s)
Aspirin , Cerebrovascular Circulation , Collateral Circulation , Disease Models, Animal , Homeostasis , Pre-Eclampsia , Rats, Sprague-Dawley , Animals , Female , Pregnancy , Aspirin/administration & dosage , Aspirin/pharmacology , Cerebrovascular Circulation/drug effects , Pre-Eclampsia/physiopathology , Pre-Eclampsia/metabolism , Pre-Eclampsia/drug therapy , Homeostasis/drug effects , Collateral Circulation/drug effects , Thromboxane A2/metabolism , Infarction, Middle Cerebral Artery/physiopathology , Infarction, Middle Cerebral Artery/metabolism , Infarction, Middle Cerebral Artery/drug therapy , Blood Flow Velocity/drug effects , Rats , Epoprostenol/metabolism , Laser-Doppler Flowmetry
11.
Eur J Pharmacol ; 978: 176774, 2024 Sep 05.
Article in English | MEDLINE | ID: mdl-38936452

ABSTRACT

AIM: Given estrogen's recognized regulatory influence on diverse metabolic and immune functions, this study sought to explore its potential impact on fibrosis and elucidate the underlying metabolic regulations. METHODS: Female mice underwent ovary removal surgery, followed by carbon tetrachloride (CCl4) administration to induce liver injury. Biochemical index analysis and histopathological examination were then conducted. The expression levels of alpha-smooth muscle actin (α-SMA), transforming growth factor-ß (TGF-ß), and collagen type 1 alpha 1 chain (COL1A1) were assessed using western blotting to further elucidate the extent of liver injury. Finally, metabolite extraction and metabolomic analysis were performed to evaluate metabolic changes. RESULTS: Ovary removal exacerbated CCl4-induced liver damage, while estrogen supplementation provided protection against hepatic changes resulting from OVX. Furthermore, estrogen mitigated liver injury induced by CCl4 treatment in vivo. Estrogen supplementation significantly restored liver damage induced by OVX and CCl4. Comparative analysis revealed significant alterations in pathways including aminoacyl-tRNA biosynthesis, glycine, serine, and threonine metabolism, lysine degradation, and taurine and hypotaurine metabolism in estrogen treatment. CONCLUSION: Estrogen supplementation alleviates liver injury induced by OVX and CCl4, highlighting its protective effects against fibrosis and associated metabolic alterations.


Subject(s)
Carbon Tetrachloride , Estrogens , Homeostasis , Liver Cirrhosis , Ovariectomy , Animals , Female , Carbon Tetrachloride/toxicity , Mice , Estrogens/pharmacology , Liver Cirrhosis/metabolism , Liver Cirrhosis/pathology , Liver Cirrhosis/drug therapy , Homeostasis/drug effects , Liver/drug effects , Liver/pathology , Liver/metabolism , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Chemical and Drug Induced Liver Injury/drug therapy , Chemical and Drug Induced Liver Injury/prevention & control , Chemical and Drug Induced Liver Injury/etiology , Mice, Inbred C57BL , Collagen Type I/metabolism , Transforming Growth Factor beta/metabolism
12.
Molecules ; 29(12)2024 Jun 15.
Article in English | MEDLINE | ID: mdl-38930917

ABSTRACT

In the field of human health research, the homeostasis of copper (Cu) is receiving increased attention due to its connection to pathological conditions, including diabetes mellitus (DM). Recent studies have demonstrated that proteins associated with Cu homeostasis, such as ATOX1, FDX1, ATP7A, ATPB, SLC31A1, p53, and UPS, also contribute to DM. Cuproptosis, characterized by Cu homeostasis dysregulation and Cu overload, has been found to cause the oligomerization of lipoylated proteins in mitochondria, loss of iron-sulfur protein, depletion of glutathione, production of reactive oxygen species, and cell death. Further research into how cuproptosis affects DM is essential to uncover its mechanism of action and identify effective interventions. In this article, we review the molecular mechanism of Cu homeostasis and the role of cuproptosis in the pathogenesis of DM. The study of small-molecule drugs that affect these proteins offers the possibility of moving from symptomatic treatment to treating the underlying causes of DM.


Subject(s)
Copper , Diabetes Mellitus , Drug Design , Homeostasis , Humans , Diabetes Mellitus/drug therapy , Diabetes Mellitus/metabolism , Copper/chemistry , Copper/metabolism , Homeostasis/drug effects , Animals , Small Molecule Libraries/pharmacology , Small Molecule Libraries/chemistry , Mitochondria/metabolism , Mitochondria/drug effects , Reactive Oxygen Species/metabolism
13.
Nutrients ; 16(12)2024 Jun 14.
Article in English | MEDLINE | ID: mdl-38931232

ABSTRACT

Abnormal glucose homeostasis is associated with metabolic syndromes including cardiovascular diseases, hypertension, type 2 diabetes mellitus, and obesity, highlighting the significance of maintaining a balanced glucose level for optimal biological function. This highlights the importance of maintaining normal glucose levels for proper biological functioning. Sulforaphane (SFN), the primary bioactive compound in broccoli from the Cruciferae or Brassicaceae family, has been shown to enhance glucose homeostasis effectively while exhibiting low cytotoxicity. This paper assesses the impact of SFN on glucose homeostasis in vitro, in vivo, and human trials, as well as the molecular mechanisms that drive its regulatory effects. New strategies have been proposed to enhance the bioavailability and targeted delivery of SFN in order to overcome inherent instability. The manuscript also covers the safety evaluations of SFN that have been documented for its production and utilization. Hence, a deeper understanding of the favorable influence and mechanism of SFN on glucose homeostasis, coupled with the fact that SFN is abundant in the human daily diet, may ultimately offer theoretical evidence to support its potential use in the food and pharmaceutical industries.


Subject(s)
Homeostasis , Isothiocyanates , Sulfoxides , Isothiocyanates/pharmacology , Isothiocyanates/administration & dosage , Humans , Homeostasis/drug effects , Animals , Glucose/metabolism , Brassica/chemistry , Blood Glucose/metabolism , Blood Glucose/drug effects , Biological Availability
14.
Int J Mol Sci ; 25(12)2024 Jun 07.
Article in English | MEDLINE | ID: mdl-38928030

ABSTRACT

Disruption of any stage of iron homeostasis, including uptake, utilization, efflux, and storage, can cause progressive damage to peripheral organs. The health hazards associated with occupational exposure to inhalation anesthetics (IA) in combination with chronic iron overload are not well documented. This study aimed to investigate changes in the concentration of essential metals in the peripheral organs of rats after iron overload in combination with IA. The aim was also to determine how iron overload in combination with IA affects tissue metal homeostasis, hepcidin-ferritin levels, and MMP levels according to physiological, functional, and tissue features. According to the obtained results, iron accumulation was most pronounced in the liver (19×), spleen (6.7×), lungs (3.1×), and kidneys (2.5×) compared to control. Iron accumulation is associated with elevated heavy metal levels and impaired essential metal concentrations due to oxidative stress (OS). Notably, the use of IA increases the iron overload toxicity, especially after Isoflurane exposure. The results show that the regulation of iron homeostasis is based on the interaction of hepcidin, ferritin, and other proteins regulated by inflammation, OS, free iron levels, erythropoiesis, and hypoxia. Long-term exposure to IA and iron leads to the development of numerous adaptation mechanisms in response to toxicity, OS, and inflammation. These adaptive mechanisms of iron regulation lead to the inhibition of MMP activity and reduction of oxidative stress, protecting the organism from possible damage.


Subject(s)
Anesthetics, Inhalation , Hepcidins , Iron-Dextran Complex , Iron , Oxidative Stress , Animals , Rats , Hepcidins/metabolism , Oxidative Stress/drug effects , Iron/metabolism , Male , Anesthetics, Inhalation/adverse effects , Anesthetics, Inhalation/toxicity , Iron-Dextran Complex/administration & dosage , Iron-Dextran Complex/toxicity , Ferritins/metabolism , Iron Overload/metabolism , Liver/drug effects , Liver/metabolism , Liver/pathology , Lung/drug effects , Lung/metabolism , Lung/pathology , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Spleen/drug effects , Spleen/metabolism , Spleen/pathology , Rats, Wistar , Homeostasis/drug effects , Isoflurane/adverse effects
15.
J Ethnopharmacol ; 333: 118486, 2024 Oct 28.
Article in English | MEDLINE | ID: mdl-38914148

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Morinda officinalis How. is a commonly used traditional Chinese herb with the pharmacological properties of tonifying liver and kidney, and enhancing bone and muscle. Iridoid glycosides are the predominant components of this plant, including monotropein, asperuloside, deacetylasperuloside and deacetylasperulosidic acid with their contents reaching more than 2%. Methotrexate (MTX) is the drug of choice for the treatment of rheumatoid arthritis (RA), but liver injury induced by MTX limits its wider use for RA. Morindaofficinalis iridoid glycoside (MOIG) is reported as having anti-RA and hepatoprotective effects, but the exact efficacy on MTX-induced liver injury and the underlying molecular mechanism remain unclear. AIM: To elucidate the mitigating effect of MOIG against liver injury in RA rats treated with MTX, and explore the possible mechanism. MATERIALS AND METHODS: The effect and mechanism of MOIG were investigated in Wistar rats with collagen-induced arthritis (CIA) which were then treated with MTX, and MTX-induced hepatocyte injury in vitro. Network pharmacological and transcriptomic analyses were conducted to predict the possible mechanisms of MOIG in mitigating MTX-induced liver injury, and lipidomic analysis was performed to further verify the regulatory effects of MOIG on lipid metabolism. BRL-3A hepatocytes were used to evaluate the regulatory effects of MOIG against MTX-associated liver injury. RESULTS: MOIG treatment enhanced the anti-RA effect of MTX, and mitigated oxidative damage, inflammation and apoptosis of liver tissues in CIA rats treated with MTX. Network pharmacological and transcriptomic analyses demonstrated that MOIG attenuated liver injury by regulating autophagy and lipid metabolism. The result of lipidomic analysis showed that MOIG reversed the disturbance of lipid metabolism of the liver tissue in CIA rats after MTX treatment. In addition, MOIG also inhibited the apoptosis, reduced the levels of lactate dehydrogenase (LDH), aspartate aminotransferase (ALT) and alanine aminotransferase (AST), regulated oxidative stress, and increased the formation of autophagosome and translocation of LC3 in the nucleus and expression of autophagy regulatory genes Beclin-1, ATG5, LC3Ⅱ, ATG7 and ATG12 in hepatocytes subjected to MTX damage. CONCLUSION: Our findings demonstrated that MOIG could ameliorate MTX-induced liver injury in the treatment of RA through increasing hepatocyte autophagy and improving lipid metabolism homeostasis.


Subject(s)
Arthritis, Experimental , Autophagy , Chemical and Drug Induced Liver Injury , Iridoid Glycosides , Lipid Metabolism , Liver , Methotrexate , Morinda , Rats, Wistar , Animals , Methotrexate/toxicity , Morinda/chemistry , Lipid Metabolism/drug effects , Chemical and Drug Induced Liver Injury/drug therapy , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Chemical and Drug Induced Liver Injury/prevention & control , Autophagy/drug effects , Rats , Iridoid Glycosides/pharmacology , Liver/drug effects , Liver/metabolism , Liver/pathology , Arthritis, Experimental/drug therapy , Arthritis, Experimental/pathology , Arthritis, Experimental/chemically induced , Arthritis, Experimental/metabolism , Male , Hepatocytes/drug effects , Hepatocytes/metabolism , Homeostasis/drug effects
16.
Inorg Chem ; 63(25): 11779-11787, 2024 Jun 24.
Article in English | MEDLINE | ID: mdl-38850241

ABSTRACT

Cisplatin is a widely used anticancer drug. In addition to inducing DNA damage, increased levels of reactive oxygen species (ROS) play a significant role in cisplatin-induced cell death. Thioredoxin-1 (Trx1), a redox regulatory protein that can scavenge ROS, has been found to eliminate cisplatin-induced ROS, while elevated Trx1 levels are associated with cisplatin resistance. However, it is unknown whether the effect of Trx1 on the cellular response to cisplatin is due to its direct reaction and how this reaction influences the activity of Trx1. In this work, we performed detailed studies of the reaction between Trx1 and cisplatin. Trx1 is highly reactive to cisplatin, and the catalytic motif of Trx1 (CGPC) is the primary binding site of cisplatin. Trx1 can bind up to 6 platinum moieties, resulting in the structural alteration and oligomerization of Trx1 depending on the degree of platination. Platination of Trx1 inhibits its interaction with ASK1, a Trx1-binding protein that regulates cell apoptosis. Furthermore, the reaction with cisplatin suppresses drug-induced ROS generation, which could be associated with drug resistance. This study provides more insight into the mechanism of action of cisplatin.


Subject(s)
Antineoplastic Agents , Cisplatin , MAP Kinase Kinase Kinase 5 , Oxidation-Reduction , Reactive Oxygen Species , Thioredoxins , Cisplatin/pharmacology , Cisplatin/chemistry , Thioredoxins/metabolism , Thioredoxins/chemistry , Humans , Reactive Oxygen Species/metabolism , Antineoplastic Agents/pharmacology , Antineoplastic Agents/chemistry , MAP Kinase Kinase Kinase 5/metabolism , Homeostasis/drug effects , Apoptosis/drug effects
17.
Int Immunopharmacol ; 137: 112418, 2024 Aug 20.
Article in English | MEDLINE | ID: mdl-38901244

ABSTRACT

Acute lung injury (ALI) is a life-threatening disease characterized by severe lung inflammation and intestinal microbiota disorder. The GPR18 receptor has been demonstrated to be a potential therapeutic target against ALI. Extracting Naringin dihydrochalcone (NDC) from the life-sustaining orange peel is known for its diverse anti-inflammatory properties, yet the specific action target remains uncertain. In the present study, we identified NDC as a potential agonist of the GPR18 receptor using virtual screening and investigated the pharmacological effects of NDC on sepsis-induced acute lung injury in rats and explored underlying mechanisms. In in vivo experiments, CLP-induced ALI model was established by cecum puncture and treated with NDC gavage one hour prior to drug administration, lung histopathology and inflammatory cytokines were evaluated, and feces were subjected to 16s rRNA sequencing and untargeted metabolomics analysis. In in vitro experiments, the anti-inflammatory properties were exerted by evaluating NDC targeting the GPR18 receptor to inhibit lipopolysaccharide (LPS)-induced secretion of TNF-α, IL-6, IL-1ß and activation of inflammatory signaling pathways in MH-S cells. Our findings showed that NDC significantly ameliorated lung damage and pro-inflammatory cytokine levels (TNF-α, IL-6, IL-1ß) in both cells and lung tissues via inhibiting the activation of STAT3, NF-κB, and NLRP3 inflammatory signaling pathways through GRP18 receptor activation. In addition, NDC can also partly reverse the imbalance of gut microbiota composition caused by CLP via increasing the proportion of Firmicutes/Bacteroidetes and Lactobacillus and decreasing the relative abundance of Proteobacteria. Meanwhile, the fecal metabolites in the NDC treatment group also significantly were changed, including decreased secretion of Phenylalanin, Glycine, and bile secretion, and increased secretion of Lysine. In conclusion, these findings suggest that NDC can alleviate sepsis-induced ALI via improving gut microbial homeostasis and metabolism and mitigate inflammation via activating GPR18 receptor. In conclusion, the results indicate that NDC, derived from the typical orange peel of food, could significantly contribute to development by enhancing intestinal microbial balance and metabolic processes, and reducing inflammation by activating the GPR18 receptor, thus mitigating sepsis-induced ALI and expanding the range of functional foods.


Subject(s)
Acute Lung Injury , Anti-Inflammatory Agents , Chalcones , Cytokines , Gastrointestinal Microbiome , Receptors, G-Protein-Coupled , Sepsis , Animals , Receptors, G-Protein-Coupled/metabolism , Gastrointestinal Microbiome/drug effects , Acute Lung Injury/drug therapy , Acute Lung Injury/pathology , Acute Lung Injury/etiology , Acute Lung Injury/microbiology , Acute Lung Injury/metabolism , Male , Sepsis/drug therapy , Sepsis/complications , Cytokines/metabolism , Rats , Chalcones/pharmacology , Chalcones/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Anti-Inflammatory Agents/pharmacology , Rats, Sprague-Dawley , Homeostasis/drug effects , Cell Line , Lung/pathology , Lung/drug effects , Disease Models, Animal , Lipopolysaccharides , Humans , Flavanones
18.
Nutrients ; 16(11)2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38892670

ABSTRACT

Tumor cells are characterized by a delicate balance between elevated oxidative stress and enhanced antioxidant capacity. This intricate equilibrium, maintained within a threshold known as redox homeostasis, offers a unique perspective for cancer treatment by modulating reactive oxygen species (ROS) levels beyond cellular tolerability, thereby disrupting this balance. However, currently used chemotherapy drugs require larger doses to increase ROS levels beyond the redox homeostasis threshold, which may cause serious side effects. How to disrupt redox homeostasis in cancer cells more effectively remains a challenge. In this study, we found that sodium selenite and docosahexaenoic acid (DHA), a polyunsaturated fatty acid extracted from marine fish, synergistically induced cytotoxic effects in colorectal cancer (CRC) cells. Physiological doses of DHA simultaneously upregulated oxidation and antioxidant levels within the threshold range without affecting cell viability. However, it rendered the cells more susceptible to reaching the upper limit of the threshold of redox homeostasis, facilitating the elevation of ROS levels beyond the threshold by combining with low doses of sodium selenite, thereby disrupting redox homeostasis and inducing MAPK-mediated paraptosis. This study highlights the synergistic anticancer effects of sodium selenite and DHA, which induce paraptosis by disrupting redox homeostasis in tumor cells. These findings offer a novel strategy for more targeted and less toxic cancer therapies for colorectal cancer treatment.


Subject(s)
Colorectal Neoplasms , Docosahexaenoic Acids , Homeostasis , MAP Kinase Signaling System , Oxidation-Reduction , Reactive Oxygen Species , Sodium Selenite , Docosahexaenoic Acids/pharmacology , Colorectal Neoplasms/drug therapy , Colorectal Neoplasms/metabolism , Sodium Selenite/pharmacology , Humans , Oxidation-Reduction/drug effects , Homeostasis/drug effects , Reactive Oxygen Species/metabolism , MAP Kinase Signaling System/drug effects , Cell Line, Tumor , Oxidative Stress/drug effects , Cell Survival/drug effects , Antioxidants/pharmacology , Drug Synergism , Antineoplastic Agents/pharmacology , Paraptosis
19.
Cell Mol Life Sci ; 81(1): 269, 2024 Jun 17.
Article in English | MEDLINE | ID: mdl-38884791

ABSTRACT

Betaine is an endogenous osmolyte that exhibits therapeutic potential by mitigating various neurological disorders. However, the underlying cellular and molecular mechanisms responsible for its neuroprotective effects remain puzzling.In this study, we describe a possible mechanism behind the positive impact of betaine in preserving neurons from excitotoxicity. Here we demonstrate that betaine at low concentration modulates the GABA uptake by GAT1 (slc6a1), the predominant GABA transporter in the central nervous system. This modulation occurs through the temporal inhibition of the transporter, wherein prolonged occupancy by betaine impedes the swift transition of the transporter to the inward conformation. Importantly, the modulatory effect of betaine on GAT1 is reversible, as the blocking of GAT1 disappears with increased extracellular GABA. Using electrophysiology, mass spectroscopy, radiolabelled cellular assay, and molecular dynamics simulation we demonstrate that betaine has a dual role in GAT1: at mM concentration acts as a slow substrate, and at µM as a temporal blocker of GABA, when it is below its K0.5. Given this unique modulatory characteristic and lack of any harmful side effects, betaine emerges as a promising neuromodulator of the inhibitory pathways improving GABA homeostasis via GAT1, thereby conferring neuroprotection against excitotoxicity.


Subject(s)
Betaine , GABA Plasma Membrane Transport Proteins , Homeostasis , gamma-Aminobutyric Acid , GABA Plasma Membrane Transport Proteins/metabolism , Betaine/pharmacology , Betaine/metabolism , gamma-Aminobutyric Acid/metabolism , Animals , Homeostasis/drug effects , Neurons/metabolism , Neurons/drug effects , Molecular Dynamics Simulation , Humans , Rats , Neuroprotective Agents/pharmacology , Neuroprotective Agents/metabolism , HEK293 Cells
20.
Ecotoxicol Environ Saf ; 281: 116563, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38878560

ABSTRACT

Evodiamine (EVO), the main active alkaloid in Evodia rutaecarpa, was shown to exert various pharmacological activities, especially anti-tumor. Currently, it is considered a potential anti-cancer drug due to its excellent anti-tumor activity, which unfortunately has adverse reactions, such as the risk of liver and kidney injury, when Evodia rutaecarpa containing EVO is used clinically. In the present study, we aim to clarify the potential toxic target organs and toxicity mechanism of EVO, an active monomer in Evodia rutaecarpa, and to develop mitigation strategies for its toxicity mechanism. Transcriptome analysis and related experiments showed that the PI3K/Akt pathway induced by calcium overload was an important step in EVO-induced apoptosis of renal cells. Specifically, intracellular calcium ions were increased, and mitochondrial calcium ions were decreased. In addition, EVO-induced calcium overload was associated with TRPV1 receptor activation. In vivo TRPV1 antagonist and calcium chelator effects were observed to significantly reduce body weight loss and renal damage in mice due to EVO toxicity. The potential nephrotoxicity of EVO was further confirmed by an in vivo test. In conclusion, TRPV1-mediated calcium overload-induced apoptosis is one of the mechanisms contributing to the nephrotoxicity of EVO due to its toxicity, whereas maintaining body calcium homeostasis is an effective measure to reduce toxicity. These studies suggest that the clinical use of EVO-containing herbal medicines should pay due attention to the changes in renal function of patients as well as the off-target effects of the drugs.


Subject(s)
Apoptosis , Calcium , Evodia , Homeostasis , Kidney , Quinazolines , Quinazolines/toxicity , Quinazolines/pharmacology , Animals , Homeostasis/drug effects , Calcium/metabolism , Mice , Apoptosis/drug effects , Kidney/drug effects , Kidney/pathology , Evodia/chemistry , Male , TRPV Cation Channels/metabolism , Calcium Chelating Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL